I Want To Be A Mentor Essay Sample

Almost all cervical carcinomas are caused by Human papillomavirus (HPV). Cervical cancer can be a life-threating disease. However, over recent years the occurrence of cervical cancer has declined as well as the chance of dying from it. A huge contributing factor to this decline is the importance of a regular pap smear. A pap smear can find cervical pre-cancer before it turns into cancer. Recently, a vaccine for HPV, has been on the market, which provides close to a 100% protection against pre-cancer and general warts. HPV and cervical cancer are two disease that are closely related. However, each disease effects not only similar populations, but also different populations, as well as having its own signs and symptoms, detection procedures,

As a member of Latino American Mentorship Program I hope to gain opportunities that were not previously available to me. As a mentor, I hope to hone my leadership skills. I want to be able to pass on what I have learned to help a new generation. That is why I am becoming a teacher. Being a part of LAMP will improve my communication skills, allow me to interact and learn from my mentees, and most importantly how to lead.

I wanted to give you an update on the process underway to identify mentors for the upcoming Beacon intern group. After getting feedback from the current group of interns and mentors, we determined a little different approach for this year. As you recall, last year, SLT identified a number of potential mentors; along with HRBP’s; we then checked to see if they had interest and confirmed approval with their leaders. We selected a final diverse group primarily based on HRBP feedback and our own personal knowledge of the individuals. We were really pleased with the outcomes. There were a couple of the mentors that just weren’t the right fit for the intern and struggled a bit connecting –however that certainly could happen again but it did help us to think

Human Papillomavirus (HPV) is a sexually transmitted virus that spreads from person to person by direct contact of infected tissue. According to the CDC, nearly all men and women will contract HPV at some point in their life (Centers for Disease Control and Prevention [CDC], 2013). HPV can cause cervical, vaginal and vulvar cancers in females. HPV can also cause anal, throat, and neck cancer in both males and females. HPV is also known to cause genital warts in both males and females. According to the National Cancer Institute (2013), “approximately 12,340 new cases of cervical cancer will be diagnosed in the US, and 4,030 US women will die

Human papillomavirus (HPV) is one of the most common sexually transmitted viral infections in the United States. There are nearly 1 out of 4 women who have been diagnosed with HPV (CDC, 2015). The Centers for Disease Control and Prevention (CDC) reported that at least 80% of women acquire a genital HPV infection by the age of 50 (CDC, 2015). HPV is an important topic that needs to be discussed because it has been estimated that 6.2 million cases of HPV has been reported (CDC, 2015). HPV is one third of all new sexual transmitted infections (CDC, 2015).

Most sexually active individuals will have detectable human papillomavirus (HPV) at least once in their lifetime. 14 million people are infected annually, and 79 million people have the prevalent infection. Approximate 5% of the cancers globally are HPV-associated anogenital or oral cancers (1). HPV is transmitted frequently between partners; more frequent transmission has been reported from females to males than from males to females (2). The incidence of anal and oral cancers related to HPV is increasing in the general population and is growing even faster among individuals who are immunocompromised because of human immunodeficiency virus (HIV) infection (3, 4). Two prophylactic vaccines (Gardasil and Cervarix) have been approved for a decade. Recently, the nonavalent vaccine including additional high-risk HPV types is promised to provide more coverage against cervical cancers (5). The HPV vaccine is recommended

Human Papilloma Virus (HPV) is a communicable, sexually transmitted disease with high prevalence rates in the general population (CDC, HPV, 2015). Although many people who contract this disease will never develop clinical symptoms, HPV may cause cancer many years later (CDC HPV, 2015). For example, one in every 142 women will develop cervical cancer due to HPV in her lifetime (CDC HPV, 2015). HPV vaccines have been developed and administered in recent years for the prevention of HPV and cervical cancer, but it must be given prior to HPV exposure (CDC HPV, 2015). The HPV vaccine is greater than 90% effective in eradication of the HPV strains that cause cancer (CDC, HPV, 2015). HPV has unique public health implications since it is rare that vaccines can prevent future cancers.

Interested in cervical cancer, Harald zur Hausen started focusing on papillomaviruses by looking into 1930’s literature: researchers Richard Shope and Peyton Rous investigated lentil-like structures on wild rabbits and found that taking extracts from these lesions and infecting domestic rabbits produced similar warts that were gradually converted into tumours. Triggered by this idea, Prof. zur Hausen tried to find herpes viruses in tumours – with no success. He then proposed the idea of using the same technique in the search of human papilloma viruses.

Human Papillomavirus (HPV) is responsible for most of both incident and prevalent Sexually Transmitted Infections in the U.S (Satterwhite et al., 2013). Approximately, 14 million Americans aged 15-59 years are newly diagnosed with HPV each year and a half of them occur among young adults aged 15-24 years (Markowitz et al., 2014). Similarly to female, the prevalence of genital HPV infection is estimated to be at least 20% or higher in male population (Dunne et al., 2006). While most HPV infection (70-90%) may be clear by itself in three years, HPV can also cause genital warts and anogenital cancers (e.g., cervical, vaginal, anal, penile cancers) (Frazer et al., 2006). In the U.S., 20,000 women and 12,000 men are diagnosed with

With the changing dimension of research studies having confirmed that HPV was a necessary cause of cervical cancer, epidemiological studies advanced to associating different strains of HPV to different anogenital pathologies, categorizing different histological forms of cervical cancer in relation to HPV strains and highlighting other risk factors that may play a prominent role or catalyze the carcinogesis process. For instance, Ngelangel et al. (1998) in their hospital-based case control studying the Philippines detected HPV-DNA in 93.8% case subjects with squamous cell carcinoma, 90.9% in case subjects with adenocarcinoma/adenosquamous carcinoma as opposed to just 9.2% of control subjects.[27] They observed the presence of fifteen different HPV types in squamous cell carcinoma, and six different HPV types in adenocarcinoma/adenosquamous carcinoma while noting that, apart from HPV 16 and HPV 18, HPV45 had the strongest association with squamous cell carcinoma. [27] The same year

Prior to June of 2006, Human Pappilomarius (HPV) was almost unheard of to the general public. But after FDA approval of Gardasil manufactured by Merck& Co., HPV vaccine became the headline of many articles and breaking news of many TV channels. Why? Let’s us explore it. According to World Health Organization (WHO), HPV worldwide is the most common sexual transmitted Disease (STD). There are more than 100 strains of HPV and in those 13 strains are known for causing cancer in human. HPV infection goes undetected majority of the time. HPV-infected victims mostly have no signs or symptoms or are there any tests available to detect it. The body immunity usually gets rid of the viruses on its own. However, with persistent infection, it may lead to genital warts and worrisome oro-genital cancers. With normal immunity, it takes about 15-20 years for cervical cancer to develop. Worldwide, cervical cancer is the second most frequent cancer. It is estimated more than 270,000 deaths from cervical cancer annually (1-6). In 2007, to prevent the devastation result of HPV-associated cancer, the National Advisory Committee on Immunization practices (ACIP) recommended Gardasil as a routine vaccination for girl’s ages 11 to 12 with a catch-up vaccination for those aged 13 to 26. Across the country, thereafter, state legislature attempt to make HPV vaccine mandated. As the result, controversy was generated. In this paper, we

Human Papillomavirus (HPV) is a sexually transmitted DNA virus that infects the skin and mucous membranes. Worldwide, the prevalence of HPV is ~11.7%. The frequency of HPV cases is much higher in developing regions, with Eastern Africa (33.6%) and the Caribbean (35.4%) having the highest prevalence. [1] Though approximately 90% of HPV infections regress to a subclinical state within two years, persistent infection may

With the development of the more organic and less formal organisational structures the role of mentors has shifted with these changes. Unlike previously where mentors where seen as formal trainers who taught newcomers the processes and got them acquainted with the cultures and the systems within the organisation. Which required good interpersonal skills and a good knowledge of the activity or tasks the mentee would have to undertake, and be able to effectively relay or demonstrate the tasks or activities to the mentee. As opposed to more recently where a mentor would have to be more of an emotional counselor and demonstrate more skills than were traditionally required from

For centuries, the etiology of cancer of the cervix remained unknown and there were several attempts by past scientists to establish the cause of cervical cancer without much success. However, the earliest breakthroughs came in the 1930s while Dr Richard Shope of the Rockefeller University was working on wild rabbits that had developed “horn”, which upon further analysis, was caused by a virus that could be transmitted. This discovery played a crucial part in the subsequent studies by Dr Zur Hausen (Cummings 2011).

Pfister, H., Krubke, J., Dietrich, W., Iftner, T., & Fuchs, P. (n.d.). Classifications of papillomaviruses--mapping the gnome. Retrieved from